ANI PHARMACEUTICALS, INC Proceeds from (Repurchase of) Equity
ANI PHARMACEUTICALS, INC (ANIP) reported Proceeds from (Repurchase of) Equity of $0 for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-02.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromRepurchaseOfEquity · last filed 2017-03-02
- ANI PHARMACEUTICALS, INC proceeds from (repurchase of) equity for the quarter ending 2015-12-31 was $0.00.
- ANI PHARMACEUTICALS, INC proceeds from (repurchase of) equity for the quarter ending 2015-09-30 was $0.00.
- ANI PHARMACEUTICALS, INC proceeds from (repurchase of) equity for the quarter ending 2015-06-30 was $0.00.
- ANI PHARMACEUTICALS, INC proceeds from (repurchase of) equity for the quarter ending 2015-03-31 was $0.00, a 100.00% decline year-over-year.
- ANI PHARMACEUTICALS, INC proceeds from (repurchase of) equity for fiscal 2016 was $0.00.
- ANI PHARMACEUTICALS, INC proceeds from (repurchase of) equity for fiscal 2015 was $0.00, a 100.00% decline from fiscal 2014.
- ANI PHARMACEUTICALS, INC proceeds from (repurchase of) equity for fiscal 2014 was $46.68M.
- ANI PHARMACEUTICALS, INC proceeds from (repurchase of) equity for fiscal 2013 was $0.00.
| Period end | Proceeds from (Repurchase of) Equity 0 month | Proceeds from (Repurchase of) Equity 3 month | Proceeds from (Repurchase of) Equity 6 month | Proceeds from (Repurchase of) Equity 9 month | Proceeds from (Repurchase of) Equity 12 month |
|---|---|---|---|---|---|
| 2016-12-31 | $0.00 10-K · filed 2017-03-02 | ||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | $0.00 derived: sum of 3 quarters · filed 2017-03-02 | $0.00 10-K · filed 2017-03-02 | |
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | $0.00 derived: sum of 2 quarters · filed 2015-11-03 | $0.00 10-Q · filed 2015-11-03 | $0.00 derived: sum of 4 quarters · filed 2017-03-02 | |
| 2015-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $0.00 10-Q · filed 2015-08-04 | $0.00 derived: sum of 3 quarters · filed 2017-03-02 | $0.00 derived: sum of 4 quarters · filed 2017-03-02 | |
| 2015-03-31 | $0.00 10-Q · filed 2015-05-05 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | $0.00 derived: sum of 3 quarters · filed 2017-03-02 | -$14.00K derived: sum of 4 quarters · filed 2017-03-02 | |
| 2014-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-02 | $0.00 derived: sum of 2 quarters · filed 2017-03-02 | -$14.00K derived: sum of 3 quarters · filed 2017-03-02 | $46.68M 10-K · filed 2017-03-02 | |
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-03 | -$14.00K derived: sum of 2 quarters · filed 2015-11-03 | $46.68M 10-Q · filed 2015-11-03 | $46.68M derived: sum of 4 quarters · filed 2016-02-23 | |
| 2014-06-30 | -$14.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-04 | $46.68M 10-Q · filed 2015-08-04 | $46.68M derived: sum of 3 quarters · filed 2016-02-23 | $46.68M derived: sum of 4 quarters · filed 2016-02-23 | |
| 2014-03-31 | $46.69M 10-Q · filed 2015-05-05 | $46.69M derived: sum of 2 quarters · filed 2016-02-23 | $46.69M derived: sum of 3 quarters · filed 2016-02-23 | $46.69M derived: sum of 4 quarters · filed 2016-02-23 | |
| 2014-03-10 | $46.70M 10-Q · filed 2014-11-10 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-23 | $0.00 derived: sum of 2 quarters · filed 2016-02-23 | $0.00 derived: sum of 3 quarters · filed 2016-02-23 | $0.00 10-K · filed 2016-02-23 | |
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-10 | $0.00 derived: sum of 2 quarters · filed 2014-11-10 | $0.00 10-Q · filed 2014-11-10 | ||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-07 | $0.00 10-Q · filed 2014-08-07 | |||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| Septerna, Inc. (SEPN) | United States | $1.783B | -63.01 |
| Xencor Inc (XNCR) | United States | $1.776B | -7.33 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Eton Pharmaceuticals, Inc. (ETON) | United States | $1.701B | 80.74 |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Xeris Biopharma Holdings, Inc. (XERS) | United States | $1.632B | -80.10 |
| Stoke Therapeutics, Inc. (STOK) | United States | $1.630B | -9.82 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |